Posted on One min read

I recently gave a talk at the 2nd International Workshop on Clinical Pharmacology of Anticancer Drugs in Madrid on the topic of Model-based TDM in Oncology.

In the talk I provided some background on model-based dosing in general, and presented some specific case studies in oncology (mainly around imatinib and busulfan). I also pointed at some future opportunities in model-informed precision dosing in oncology.

The slides of this talk are provided below. Feel free to reach out with any feedback!

Model-based TDM in oncology (PDF)